Page 3 - Hydroxychloroquine

Use of hydroxychloroquin for Covid-19 treatment banned by France govt

The decision came a day after French health organisations, namely, the HCSP health advisory and ANSM drugs agency, advised against using hydroxychloroquine for Covid-19 treatment

Trust ICMR call on HCQ in Covid treatment: CSIR's Shekhar Mande

Indian researchers have not found any major side-effects of HCQ and its use should be continued in preventive treatment for Covid-19, ICMR said

India coronavirus dispatch: 'Infodemic' is as dangerous as the virus itself

From Kerala's smart testing and community care, to hospitals putting off elective surgeries, and the progress with solidarity trials so far - read these and more in today's India dispatch

India records over 6,500 new Covid-19 cases in 24 hrs, death toll at 4,167

Confirmed cases surge past 145,000; fatality rate down from 3.3% to 2.87%

The Covid curve

Primary responsibility for containing the virus is now with society

Provide real-time data on availability, consumption of HCQ: Health Ministry

The Health Ministry is centrally procuring HCQ (200mg to be used in proportionality in lieu of 400 mg tablets) and distributing to the states/UTs through government medical store depot in New Delhi

Covid-19: India ramps up testing, WHO temporarily suspends HCQ trials

Let's take a look at major coronavirus related developments in India and elsewhere

Covid-19: WHO halts trial of hydroxychloroquine, awaits more safety data

"It's important to continue to gather evidence on the efficacy and safety of hydroxychloroquine," WHO Chief Scientist Soumya Swaminathan said at a press briefing in Geneva

Covid-19 crisis: WHO pauses trial of hydroxychloroquine on safety concerns

Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus

I am doing fine after taking a two-week course of hydroxychloroquine: Trump

Trump has spent weeks pushing the drug as a potential treatment or prophylaxis for Covid-19 against the cautionary advice of many of his administration's top medical professionals

Continue hydroxychloroquine as preventive therapy against Covid-19: ICMR

So far, only high-risk individuals, including asymptomatic health care workers, were given the drug along with household contacts of Covid patients

ICMR's new advisory expands use of HCQ but cautions against false security

According to the revised advisory, the report of an in-vitro testing of HCQ for antiviral efficacy showed reduction of infectivity and log reduction in viral RNA copy of SARs-CoV2

Covid-19 updates: Biggest single-day spike in global cases; 5,609 in India

While China has the highest recovery rate globally, with 94 per cent of its confirmed cases having recovered, followed by Germany and Iran, India's recovery rate, stands at 40 per cent currently

WHO reports biggest single-day jump in Covid cases; over 100,000 infected

The global tally of cases is nearing five million, with more than 324,000 deaths, according to figures collected by Johns Hopkins University's Coronavirus Resource Centre

Only 6.39% Covid-19 cases needed hospital support; recovery rate now at 40%

Total count at 1,06,750, of which 61,149 are active. Some 6.9% of those under treatment are critical; death toll at 3,303

Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs

The company's shares, which have more than quadrupled this year, surged 17.7% to $17.13 in trading before the bell

Trump says he has been taking Hydroxychloroquine despite FDA warning

The President, according to The Hill report, said he consulted with the White House doctor about taking the drug, but it was not explicitly recommended for him

Covid-19 update: India's cases now exceed China's; US donates ventilators

US President Donald Trump took to Twitter to announce sending ventilators to India. In the same tweet, he praised Indian-Americans as "great" scientists and researchers

Lockdown serves domestic pharma the bitter pill: April growth slips

Lack of fresh prescriptions drags growth in acute therapies

Humble leaders, please

This is one of those crises where it does not only matter that you do something, but how you do it